Page last updated: 2024-10-30

leflunomide and Glomerulonephritis, Minimal Change

leflunomide has been researched along with Glomerulonephritis, Minimal Change in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research Excerpts

ExcerptRelevanceReference
" During the treatment, 8 patients had adverse effects which could be well tolerated."1.39Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease. ( Huang, J; Li, J; Liu, G; Xu, R; Zhang, Y; Zhou, J, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Zhao, C1
Cui, Z1
Zhang, Y2
Wang, F1
Wang, X1
Cheng, X1
Meng, L1
Liu, G2
Zhao, M1
Zhou, J1
Li, J1
Xu, R1
Huang, J1

Other Studies

2 other studies available for leflunomide and Glomerulonephritis, Minimal Change

ArticleYear
Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis.
    Chinese medical journal, 2022, 04-05, Volume: 135, Issue:7

    Topics: Adult; Cyclosporine; Glomerulosclerosis, Focal Segmental; Humans; Leflunomide; Nephrosis, Lipoid; Ne

2022
Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease.
    Clinical nephrology, 2013, Volume: 80, Issue:2

    Topics: Adolescent; Adult; Drug Resistance; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomid

2013